A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Kestrel Therapeutics, Inc.
Kestrel Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
Medical College of Wisconsin
Pfizer
Barbara Ann Karmanos Cancer Institute
Fox Chase Cancer Center
Chongqing Precision Biotech Co., Ltd
Affiliated Cancer Hospital of Shantou University Medical College
City of Hope Medical Center
Columbia University
University of Texas Southwestern Medical Center
Chongqing Precision Biotech Co., Ltd